Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudeep Gupta

Showing results (231-240 of 349) with videos related to

Pageof 35
Sort By:
The Indian Journal of Medical Research|May 10, 2025
Circulating tumour DNA as a promising biomarker for breast cancer diagnosis & treatment monitoringRiddhi Ursekar, Rohan Chaubal, Khushboo A Gandhi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2017
Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'Jyoti Bajpai, Arun Chandrasekharan, Vikas Talreja, et al.
BJUI Compass|February 9, 2026
Survival outcomes in prostate cancer patients treated at an Indian tertiary care centreAswathy P, Sivaranjini Kannusamy, Amey Oak, et al.
Medical Oncology (Northwood, London, England)|April 12, 2020
Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapyBhausaheb Bagal, Rohit Kumar, Tarang Gaur, et al.
South Asian Journal of Cancer|February 7, 2018
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burdenAmit Joshi, Vijay M Patil, Vanita Noronha, et al.
The Indian Journal of Medical Research|April 4, 2026
Clinically actionable alterations in Indian breast cancer patients derived through whole transcriptome sequencingNilesh Gardi, Rohan Chaubal, Khushboo A Gandhi, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Patterns of Relapse After Adjuvant Chemoradiation for Cervical Cancer in a Phase 3 Clinical Trial (PARCER): An Evaluation of Updated NRG Oncology/RTOG Target Delineation GuidelinesPrachi Mittal, Supriya Chopra, Mayuri Charnalia, et al.
Cancer Reports (Hoboken, N.J.)|July 17, 2020
Compliance to treatment guidelines and survival in women undergoing interval debulking surgery for advanced epithelial ovarian cancerThumkur S Shylasree, Abhay K Kattepur, Monisha Gupta, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2022
Serial Bone Density Changes in Women Undergoing Pelvic (Chemo) Radiation: Results From the PARCER TrialPradnya Chopade, Supriya Chopra, Jeevanshu Jain, et al.
Applied Health Economics and Health Policy|March 6, 2024
Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in IndiaJyoti Dixit, Pankaj Malhotra, Nikita Mehra, et al.
Pageof 35

Showing results (231-240 of 349) with videos related to

Sort By:
Pageof 35
The Indian Journal of Medical Research|May 10, 2025
Circulating tumour DNA as a promising biomarker for breast cancer diagnosis & treatment monitoringRiddhi Ursekar, Rohan Chaubal, Khushboo A Gandhi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2017
Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'Jyoti Bajpai, Arun Chandrasekharan, Vikas Talreja, et al.
BJUI Compass|February 9, 2026
Survival outcomes in prostate cancer patients treated at an Indian tertiary care centreAswathy P, Sivaranjini Kannusamy, Amey Oak, et al.
Medical Oncology (Northwood, London, England)|April 12, 2020
Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapyBhausaheb Bagal, Rohit Kumar, Tarang Gaur, et al.
South Asian Journal of Cancer|February 7, 2018
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burdenAmit Joshi, Vijay M Patil, Vanita Noronha, et al.
The Indian Journal of Medical Research|April 4, 2026
Clinically actionable alterations in Indian breast cancer patients derived through whole transcriptome sequencingNilesh Gardi, Rohan Chaubal, Khushboo A Gandhi, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Patterns of Relapse After Adjuvant Chemoradiation for Cervical Cancer in a Phase 3 Clinical Trial (PARCER): An Evaluation of Updated NRG Oncology/RTOG Target Delineation GuidelinesPrachi Mittal, Supriya Chopra, Mayuri Charnalia, et al.
Cancer Reports (Hoboken, N.J.)|July 17, 2020
Compliance to treatment guidelines and survival in women undergoing interval debulking surgery for advanced epithelial ovarian cancerThumkur S Shylasree, Abhay K Kattepur, Monisha Gupta, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2022
Serial Bone Density Changes in Women Undergoing Pelvic (Chemo) Radiation: Results From the PARCER TrialPradnya Chopade, Supriya Chopra, Jeevanshu Jain, et al.
Applied Health Economics and Health Policy|March 6, 2024
Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in IndiaJyoti Dixit, Pankaj Malhotra, Nikita Mehra, et al.
Pageof 35